#1 Clinical Trials Search in Europe

Chlorpromazine Hydrochloride

Chlorpromazine Hydrochloride, a versatile antipsychotic medication, has been the subject of various clinical trials exploring its potential uses beyond its primary psychiatric applications. These studies investigate its efficacy in treating conditions ranging from agitated delirium to COVID-19, as well as its use in medical imaging procedures and cancer treatment. This article summarizes key findings from recent clinical trials involving Chlorpromazine Hydrochloride, highlighting its diverse potential applications in modern medicine.

Table of Contents

What is Chlorpromazine Hydrochloride?

Chlorpromazine hydrochloride is a medication that has been used for over half a century in the treatment of various medical conditions. It belongs to a class of drugs called antipsychotics. Chlorpromazine is also known by several other names, including Largactil, Thorazine, and Neurazine[1][2].

Medical Uses of Chlorpromazine

Chlorpromazine is primarily used to treat mental health conditions, but it has several other medical applications as well. Some of the conditions it is used to treat include:

  • Psychotic disorders: Chlorpromazine helps manage symptoms of conditions like schizophrenia[3].
  • Nausea and vomiting: It can help control severe nausea and vomiting in some patients[3].
  • Pre-surgery anxiety: Chlorpromazine may be used to relieve restlessness and apprehension before surgery[3].
  • Acute intermittent porphyria: This is a rare inherited blood disorder that chlorpromazine can help manage[3].
  • Tetanus: Chlorpromazine can be used as an additional treatment for tetanus, a serious bacterial infection[3].
  • Manic episodes: It can help control symptoms of manic-depressive illness (also known as bipolar disorder)[3].
  • Intractable hiccups: In some cases, chlorpromazine is used to relieve persistent hiccups that don’t respond to other treatments[3].

How Chlorpromazine Works

Chlorpromazine works by affecting various chemical systems in the brain. Its main action is blocking a specific type of receptor called the dopamine D2 receptor. This helps to reduce excessive dopamine activity in the brain, which is thought to be responsible for some symptoms of psychotic disorders[4].

In addition to its effects on dopamine, chlorpromazine also influences other brain chemicals and systems. This wide-ranging action contributes to its various uses in medicine[4].

How Chlorpromazine is Administered

Chlorpromazine can be given in several ways, depending on the condition being treated and the patient’s needs:

  • Oral tablets: The most common form is tablets taken by mouth. The dosage can vary widely, from as low as 12.5 mg to as high as 300 mg per day, depending on the condition and the patient’s response[1].
  • Intravenous (IV) injection: In some cases, particularly in hospital settings, chlorpromazine may be given by injection into a vein[1].
  • Retrobulbar injection: In very specific cases, such as for treating severe eye pain in blind eyes, chlorpromazine may be injected behind the eye[5].

Potential Side Effects

Like all medications, chlorpromazine can cause side effects. Some potential side effects include:

  • Drowsiness or sedation
  • Changes in heart rate or blood pressure
  • Movement disorders (extrapyramidal symptoms)
  • Changes in blood cell counts
  • Liver function changes
  • Alterations in heart rhythm (seen on ECG)

It’s important to note that not everyone experiences these side effects, and your doctor will monitor you closely while you’re taking this medication[1].

Current Research and New Potential Uses

Researchers are currently exploring new potential uses for chlorpromazine. Some areas of ongoing research include:

  • COVID-19 treatment: Some studies are investigating whether chlorpromazine could help treat COVID-19 by interfering with the virus’s ability to enter cells[1].
  • Cancer treatment: Researchers are studying whether chlorpromazine could be useful in treating certain types of cancer, including glioblastoma (a type of brain cancer) and colon cancer. It appears to have effects that could slow cancer cell growth[4][6].
  • Delirium management: Studies are looking at how chlorpromazine compares to other medications in managing agitated delirium, a state of severe confusion that can occur in hospitalized patients[2].

It’s important to remember that these are areas of ongoing research, and chlorpromazine is not currently approved for these uses. Always follow your doctor’s advice about medications and never use a medication for a purpose other than what it was prescribed for.

Study Focus Key Findings/Objectives Potential Impact
Bioavailability Investigating intrasubject variability in Chlorpromazine Hydrochloride bioavailability May lead to improved dosing strategies and efficacy
COVID-19 Treatment Exploring Chlorpromazine’s potential antiviral effects against SARS-CoV-2 Could provide a new treatment option for COVID-19 patients
Cancer Treatment Evaluating Chlorpromazine as an adjuvant therapy for colon cancer and glioblastoma May improve outcomes in cancer treatment
Pain Management Using Chlorpromazine for managing pain in blind eyes Could offer alternative to more invasive treatments
Pediatric Sedation Comparing Chlorpromazine to Pentobarbital for pediatric imaging procedures May improve sedation protocols for children
Delirium Management Assessing Chlorpromazine’s efficacy in managing agitated delirium Could provide new options for delirium treatment

FAQ

  • What is Chlorpromazine Hydrochloride primarily used for? Chlorpromazine Hydrochloride is primarily used as an antipsychotic medication for treating psychiatric disorders, including schizophrenia and manic episodes of bipolar disorder. It's also used to control nausea, vomiting, and restlessness before surgery.
  • Are there any potential new uses for Chlorpromazine being studied? Yes, recent clinical trials have explored using Chlorpromazine for treating COVID-19, managing agitated delirium, as an adjuvant therapy in cancer treatment, and as a sedative for pediatric imaging procedures.
  • How is Chlorpromazine being studied in relation to COVID-19? Some clinical trials are investigating whether adding Chlorpromazine to standard COVID-19 treatment protocols can improve outcomes for hospitalized patients with respiratory symptoms. Researchers are studying its potential antiviral effects and ability to reduce the severity of COVID-19 symptoms.
  • What are the potential side effects of Chlorpromazine? Common side effects can include drowsiness, dizziness, and dry mouth. More serious side effects may include changes in heart rhythm, movement disorders, and in rare cases, a condition called neuroleptic malignant syndrome. The specific trials mentioned are also monitoring for any adverse effects.
  • How is Chlorpromazine administered in these clinical trials? The administration of Chlorpromazine varies depending on the study. It may be given orally, intravenously, or even as a retrobulbar injection in some cases. Dosages also vary based on the condition being treated and the specific trial protocol.

Ongoing Clinical Trials on Chlorpromazine Hydrochloride

  • Study on the Effects of Vortioxetine on Cognitive Function in Patients with Early Schizophrenia

    Recruiting

    4 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

  • Study on Reducing Antipsychotic Dose vs. Maintenance Treatment for Patients with Schizophrenia Using Haloperidol Decanoate, Risperidone, and Amisulpride

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France

Glossary

  • Bioequivalence: The property of two drugs having the same biological effect and availability in the body. This is often studied when comparing generic versions of a drug to the original brand-name version.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Antipsychotic: A type of medication used to treat symptoms of psychosis, such as hallucinations or delusions, often associated with conditions like schizophrenia.
  • Intrasubject variability: The variation in drug response or effects within the same individual over time or under different conditions.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
  • Adjuvant therapy: Additional treatment given after the primary treatment to increase the chances of a successful outcome.
  • Glioblastoma multiforme: An aggressive type of cancer that occurs in the brain or spinal cord.
  • Neuroleptic: Another term for antipsychotic medications, which are used to manage psychosis.
  • Delirium: A serious disturbance in mental abilities that results in confused thinking and reduced awareness of the environment.
  • Phthisis bulbi: A shrunken, non-functional eye, often as a result of severe injury or disease.

References

  1. https://clinicaltrials.gov/study/NCT04366739
  2. https://clinicaltrials.gov/study/NCT05431595
  3. https://clinicaltrials.gov/study/NCT02943213
  4. https://clinicaltrials.gov/study/NCT04224441
  5. https://clinicaltrials.gov/study/NCT01404364
  6. https://clinicaltrials.gov/study/NCT05433402